Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-Fluoro-2-(1H-pyrazol-1-yl)benzoic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1214622-53-3

Post Buying Request

1214622-53-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1214622-53-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1214622-53-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,4,6,2 and 2 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1214622-53:
(9*1)+(8*2)+(7*1)+(6*4)+(5*6)+(4*2)+(3*2)+(2*5)+(1*3)=113
113 % 10 = 3
So 1214622-53-3 is a valid CAS Registry Number.

1214622-53-3Downstream Products

1214622-53-3Relevant articles and documents

DISUBSTITUTED OCTAHY-DROPYRROLO [3,4-C] PYRROLES AS OREXIN RECEPTOR MODULATORS

-

Page/Page column 96-97, (2012/11/07)

Disubstituted octahydropyrrolo[3,4-c]pyrrole compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.

FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS

-

Page/Page column 67, (2011/05/06)

Disubstituted 3,8-diaza-bicyclo[4.2.0]octane and 3,6-diazabicyclo [3.2.0]heptane compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.

FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS

-

Page/Page column 62, (2011/05/06)

Certain disubstituted 3,8-diaza-bicyclo[4.2.0]octane and 3,6-diazabicyclo [3.2.0]heptane are described, which are useful as orexin inhibitors. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1214622-53-3